Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 27, 2022
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
David Nierengarten Maintained (SWTX) at Buy with Decreased Target to $50 on, May 27th, 2022
David Nierengarten of Wedbush, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Decreased Target from $110 to $50 on, May 27th, 2022.
David has made no other calls on SWTX in the last 4 months.
There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $82 on, Tuesday, May 24th, 2022
